Drug Profile
Jasplakinolide
Alternative Names: Jaspamide; NSC 613009Latest Information Update: 27 Jul 2001
Price :
$50
*
At a glance
- Originator National Cancer Institute (USA)
- Class Antineoplastics; Depsipeptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer